The global Measle Vaccine market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Measle Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Measle Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Measle Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Measle Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Measle Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Measle Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Measle Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Biovac, McKesson Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Measle Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Inactivated Vaccine
Attenuated Vaccine
麻豆原创 segment by Application
Hospital
Scientific Research
Others
Major players covered
Merck
Biovac
McKesson Medical
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measle Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Measle Vaccine, with price, sales quantity, revenue, and global market share of Measle Vaccine from 2020 to 2025.
Chapter 3, the Measle Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measle Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Measle Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Measle Vaccine.
Chapter 14 and 15, to describe Measle Vaccine sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Measle Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Inactivated Vaccine
1.3.3 Attenuated Vaccine
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Measle Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Scientific Research
1.4.4 Others
1.5 Global Measle Vaccine 麻豆原创 Size & Forecast
1.5.1 Global Measle Vaccine Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Measle Vaccine Sales Quantity (2020-2031)
1.5.3 Global Measle Vaccine Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Measle Vaccine Product and Services
2.1.4 Merck Measle Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Merck Recent Developments/Updates
2.2 Biovac
2.2.1 Biovac Details
2.2.2 Biovac Major Business
2.2.3 Biovac Measle Vaccine Product and Services
2.2.4 Biovac Measle Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Biovac Recent Developments/Updates
2.3 McKesson Medical
2.3.1 McKesson Medical Details
2.3.2 McKesson Medical Major Business
2.3.3 McKesson Medical Measle Vaccine Product and Services
2.3.4 McKesson Medical Measle Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 McKesson Medical Recent Developments/Updates
3 Competitive Environment: Measle Vaccine by Manufacturer
3.1 Global Measle Vaccine Sales Quantity by Manufacturer (2020-2025)
3.2 Global Measle Vaccine Revenue by Manufacturer (2020-2025)
3.3 Global Measle Vaccine Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Measle Vaccine by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Measle Vaccine Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Measle Vaccine Manufacturer 麻豆原创 Share in 2024
3.5 Measle Vaccine 麻豆原创: Overall Company Footprint Analysis
3.5.1 Measle Vaccine 麻豆原创: Region Footprint
3.5.2 Measle Vaccine 麻豆原创: Company Product Type Footprint
3.5.3 Measle Vaccine 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Measle Vaccine 麻豆原创 Size by Region
4.1.1 Global Measle Vaccine Sales Quantity by Region (2020-2031)
4.1.2 Global Measle Vaccine Consumption Value by Region (2020-2031)
4.1.3 Global Measle Vaccine Average Price by Region (2020-2031)
4.2 North America Measle Vaccine Consumption Value (2020-2031)
4.3 Europe Measle Vaccine Consumption Value (2020-2031)
4.4 Asia-Pacific Measle Vaccine Consumption Value (2020-2031)
4.5 South America Measle Vaccine Consumption Value (2020-2031)
4.6 Middle East & Africa Measle Vaccine Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Measle Vaccine Sales Quantity by Type (2020-2031)
5.2 Global Measle Vaccine Consumption Value by Type (2020-2031)
5.3 Global Measle Vaccine Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Measle Vaccine Sales Quantity by Application (2020-2031)
6.2 Global Measle Vaccine Consumption Value by Application (2020-2031)
6.3 Global Measle Vaccine Average Price by Application (2020-2031)
7 North America
7.1 North America Measle Vaccine Sales Quantity by Type (2020-2031)
7.2 North America Measle Vaccine Sales Quantity by Application (2020-2031)
7.3 North America Measle Vaccine 麻豆原创 Size by Country
7.3.1 North America Measle Vaccine Sales Quantity by Country (2020-2031)
7.3.2 North America Measle Vaccine Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Measle Vaccine Sales Quantity by Type (2020-2031)
8.2 Europe Measle Vaccine Sales Quantity by Application (2020-2031)
8.3 Europe Measle Vaccine 麻豆原创 Size by Country
8.3.1 Europe Measle Vaccine Sales Quantity by Country (2020-2031)
8.3.2 Europe Measle Vaccine Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Measle Vaccine Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Measle Vaccine Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Measle Vaccine 麻豆原创 Size by Region
9.3.1 Asia-Pacific Measle Vaccine Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Measle Vaccine Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Measle Vaccine Sales Quantity by Type (2020-2031)
10.2 South America Measle Vaccine Sales Quantity by Application (2020-2031)
10.3 South America Measle Vaccine 麻豆原创 Size by Country
10.3.1 South America Measle Vaccine Sales Quantity by Country (2020-2031)
10.3.2 South America Measle Vaccine Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Measle Vaccine Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Measle Vaccine Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Measle Vaccine 麻豆原创 Size by Country
11.3.1 Middle East & Africa Measle Vaccine Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Measle Vaccine Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Measle Vaccine 麻豆原创 Drivers
12.2 Measle Vaccine 麻豆原创 Restraints
12.3 Measle Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Measle Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Measle Vaccine
13.3 Measle Vaccine Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Measle Vaccine Typical Distributors
14.3 Measle Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Merck
Biovac
McKesson Medical
听
听
*If Applicable.
